leisure time -WSS

leisure time

author：leisure time 2025-09-27 09:45:38 - browse：89

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： How to fix the rural physician shortage in the U.S.

WSS

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

JPM 2024: Verve Therapeutics looks to mainstream genome editing

HHS names first

Risky weight loss products often used by teens globally, per study

Idaho abortion case may prompt more restrictions in other states

Biotech companies concerned about China biosecurity crackdown

focus

leisure time

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Obesity now affects over 1 billion people worldwide, study finds

Bright Health sells Medicare Advantage business to Molina

DeSantis can now import cheaper drugs. But will Biden get credit?

Hollywood unions extend contract negotiations for actors

Change Healthcare cyberattack outage could last weeks

Medicare proposal to cover medical devices draws a mixed reaction

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New menopause drug shows promise in relief for hot flashes

explore

How I ended up pumping milk in a bathroom stall at JPM 2024

RSV vaccines may be linked to small increased risk of developing GBS

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

As JPM 2024 winds down, some health tech firms project optimism

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

New England Journal of Medicine addresses racist history, slavery

entertainment

hotspot

focus

entertainment